Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002373975 | SCV002683799 | uncertain significance | Cardiovascular phenotype | 2018-05-07 | criteria provided, single submitter | clinical testing | The p.G3137D variant (also known as c.9410G>A), located in coding exon 39 of the TTN gene, results from a G to A substitution at nucleotide position 9410. The glycine at codon 3137 is replaced by aspartic acid, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |